Literature DB >> 20391499

Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001-2005.

Jeffrey J Sacks1, Yao-Hua Luo, Charles G Helmick.   

Abstract

OBJECTIVE: To estimate the overall prevalence of medically-treated arthritis and other rheumatic conditions (AORC) for adults, the prevalence of specific medically-treated conditions, and the overall annual number of visits for these conditions in the ambulatory health care system.
METHODS: We used data from the 2001-2005 National Ambulatory Medical Care Survey and 2001-2005 National Hospital Ambulatory Medical Care Survey to estimate annual ambulatory health care visits for the International Classification of Diseases, Ninth Revision, Clinical Modification codes thought to represent AORC. Using data on the number of prior annual visits per patient per condition, we converted the visit estimates into prevalence estimates of adults age > or =18 years with medically-treated AORC overall and for specific conditions.
RESULTS: The overall prevalence estimate of adults with medically-treated AORC was 29,150,000 adults (95% confidence interval [95% CI] 26,473,000-31,826,000) and accounted for 77,887,300 ambulatory care visits (95% CI 71,266,000-84,508,000). The top 5 most prevalent conditions were osteoarthritis and allied disorders, unspecified joint disorders, peripheral enthesopathies, unspecified arthropathies, and other disorders of synovium, tendon, or bursa.
CONCLUSION: The advantage of our approach is that it uses existing rather than expensive new surveys for tracking the prevalence of medically-treated AORC overall and tracking the prevalence of difficult to measure specific conditions. The estimates are data based and national in scope. More relevantly, they better estimate the numbers of persons whose AORC impacts on the ambulatory health care system.

Entities:  

Mesh:

Year:  2010        PMID: 20391499     DOI: 10.1002/acr.20041

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  46 in total

1.  Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis.

Authors:  Andrew Hresko; Tzu-Chieh Lin; Daniel H Solomon
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-10       Impact factor: 4.794

2.  Rheumatoid arthritis causing diffuse alveolar haemorrhage: a novel therapeutic approach.

Authors:  Afaf Osman; Panagis Galiatsatos; Sonali Bose; Sonye Danoff
Journal:  BMJ Case Rep       Date:  2017-06-14

Review 3.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

4.  Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.

Authors:  Theresa M Hunter; Natalie N Boytsov; Xiang Zhang; Krista Schroeder; Kaleb Michaud; Andre B Araujo
Journal:  Rheumatol Int       Date:  2017-04-28       Impact factor: 2.631

5.  Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

Authors:  Tracy J Doyle; Avignat S Patel; Hiroto Hatabu; Mizuki Nishino; Guodong Wu; Juan C Osorio; Maria F Golzarri; Andres Traslosheros; Sarah G Chu; Michelle L Frits; Christine K Iannaccone; Diane Koontz; Carl Fuhrman; Michael E Weinblatt; Souheil Y El-Chemaly; George R Washko; Gary M Hunninghake; Augustine M K Choi; Paul F Dellaripa; Chester V Oddis; Nancy A Shadick; Dana P Ascherman; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

6.  New diagnosis of rheumatoid arthritis during the third trimester of pregnancy.

Authors:  Sana Qureshi; Mahsa Kanzali; Syed Farhan Rizvi; Niharika Joolukuntla; Barry Fomberstein
Journal:  Womens Health (Lond)       Date:  2016-07

7.  Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.

Authors:  Leticia Kawano-Dourado; Tracy J Doyle; Karina Bonfiglioli; Márcio V Y Sawamura; Renato H Nakagawa; Fábio E Arimura; Hye J Lee; Diana Arrais de Souza Rangel; Cleonice Bueno; Carlos R R Carvalho; Maria Laura Sabbag; Camila Molina; Ivan O Rosas; Ronaldo A Kairalla
Journal:  Chest       Date:  2020-05-16       Impact factor: 9.410

Review 8.  Mesenchymal stem cells injections for knee osteoarthritis: a systematic overview.

Authors:  Dan Xing; Qi Wang; Ziyi Yang; Yunfei Hou; Wei Zhang; Yaolong Chen; Jianhao Lin
Journal:  Rheumatol Int       Date:  2017-12-22       Impact factor: 2.631

9.  A public health approach to addressing arthritis in older adults: the most common cause of disability.

Authors:  Jennifer M Hootman; Charles G Helmick; Teresa J Brady
Journal:  Am J Public Health       Date:  2012-01-19       Impact factor: 9.308

10.  Does knee replacement surgery for osteoarthritis improve survival? The jury is still out.

Authors:  Devyani Misra; Na Lu; David Felson; Hyon K Choi; John Seeger; Thomas Einhorn; Tuhina Neogi; Yuqing Zhang
Journal:  Ann Rheum Dis       Date:  2016-05-17       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.